Researchers found that patients with non-irrhotic liver cancer had a high prevalence of diabetes and elevated body mass indexes (BMI) despite a lack of steatosis. In other findings, BMI was also linked with adenoma recurrence in the short ad long-erm; the prevalence of angiographically-roven coronary disease in the non-alcoholic fatty liver disease (NAFLD) cohort was 61 percent compared to 26 percent in the non-AFLD controls.
- New studies highlight obesity's impact on gastrointestinal healthMon, 18 Oct 2010, 10:04:20 EDT
- Fatty liver disease may raise heart disease risk in overweight, obese kidsMon, 30 Jun 2008, 23:29:05 EDT
- Hyperferritinemia is another surrogate marker of advanced liver diseaseWed, 13 May 2009, 9:49:53 EDT
- Liver disease responsible for most alcohol-related illness and deathsThu, 23 Apr 2009, 4:43:28 EDT
- Aerobic exercise may improve non-alcoholic fatty liver diseaseWed, 13 Apr 2011, 13:40:35 EDT